Figure 3.
Timeline of FDA approvals of epigenetic-modulating therapies in hematological cancers. Source: https://www.accessdata.fda.gov/scripts/cder/daf/
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.